EPS Bio TechnologyROCO:4183 63 Dividend Yield % is 4.79% as of Jul. 13, 2026, which is 27% above its 10-year median of 3.78. GuruFocus rates ROCO:4183 with a GF Score™ of 63/100 and a GF Value™ of NT$22.94 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 327 Medical Devices & Instruments companies, EPS Bio Technology ranks better than 88.07% on this metric.
As of today (2026-07-13), the Trailing Annual Dividend Yield of EPS Bio Technology is 4.79%.
The historical rank and industry rank for EPS Bio Technology's Dividend Yield % or its related term are showing as below:
ROCO:4183'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.93 Med: 3.78 Max: 8.48
Current: 4.79
During the past 13 years, the highest Dividend Yield of EPS Bio Technology was 8.48%. The lowest was 0.93%. And the median was 3.78%.
ROCO:4183's Dividend Yield % is ranked better than 88.07% of 327
companies
in the Medical Devices & Instruments industry
Industry Median: 1.92
vs ROCO:4183: 4.79
During the past 12 months, EPS Bio Technology's average Dividends Per Share Growth Rate was -16.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -1.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -3.10% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of EPS Bio Technology was 102.70% per year. The lowest was -12.60% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
EPS Bio Technology (ROCO:4183) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
EPS Bio Technology Dividend Yield % Historical Data
* Premium members only.
The historical data trend for EPS Bio Technology's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4183 vs ABT, SYK, MDT: Dividend Yield % Comparison
For the Medical Devices subindustry, EPS Bio Technology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EPS Bio Technology Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EPS Bio Technology's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where EPS Bio Technology's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
EPS Bio Technology Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 0.670000
2025-08-28
2025-08-29
2025-09-26
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
EPS Bio Technology's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS Bio Technology (ROCO:4183) has a Dividend Yield % of 4.79% as of Jul. 13, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on EPS Bio Technology and its competitors. This is 27% above median its historical median of 3.78. Over the past decade, EPS Bio Technology's Dividend Yield % has ranged from 0.93 to 8.48. According to the industry distribution chart, EPS Bio Technology ranks #39 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 11.9%.
Is EPS Bio Technology's Dividend Yield % too high?
EPS Bio Technology's current Dividend Yield % of 4.79% is 27% above median its 10-year median of 3.78. Over the past 10 years, this metric has ranged from a low of 0.93 to a high of 8.48. The Medical Devices & Instruments industry median Dividend Yield % is 1.92. EPS Bio Technology's value of 4.79% is 149.5% above this industry median. Based on the distribution chart, EPS Bio Technology ranks #39 out of 327 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, EPS Bio Technology has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EPS Bio Technology's Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EPS Bio Technology ranks #39 out of 327 companies for Dividend Yield %. This places EPS Bio Technology in the top 12% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.92. EPS Bio Technology's value of 4.79% is 149.5% above this benchmark. Historically, EPS Bio Technology's own Dividend Yield % has ranged from 0.93 to 8.48 over the past decade. While the company's 10-year median is 3.78 vs. the industry median of 1.92, EPS Bio Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.92, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EPS Bio Technology's current Dividend Yield % of 4.79% is 149.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on EPS Bio Technology and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EPS Bio Technology's current Dividend Yield % is 4.79%, which is 27% above median its own 10-year median of 3.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EPS Bio Technology stock overvalued right now?
Based on GuruFocus' analysis, EPS Bio Technology (ROCO:4183) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$22.94, compared to a current price of NT$14.00 — trading 39% below its estimated fair value. The current Dividend Yield % is 4.79%, which is 27% above median its 10-year median of 3.78 and 149.5% above the Medical Devices & Instruments industry median of 1.92. EPS Bio Technology's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For EPS Bio Technology (ROCO:4183), the current Dividend Yield % is 4.79% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EPS Bio Technology (ROCO:4183) Overvalued in 2026?
Based on GuruFocus' analysis, EPS Bio Technology stock appears to be undervalued.
The current stock price of NT$14.00 is trading 39% below its estimated GF Value™ of NT$22.94.
GuruFocus considers EPS Bio Technology to be Significantly Undervalued.
Key valuation signals for ROCO:4183:
Dividend Yield %: 4.79% (27% above median its 10-year median of 3.78)
GF Value™: NT$22.94 vs. price of NT$14.00 (39% below fair value)
Industry Position: 149.5% above the Medical Devices & Instruments median (#39 of 327)
No single metric tells the full story. See the ROCO:4183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EPS Bio Technology Corp operates in medical equipment manufacturing, international trade, intellectual property, and research, design, development, manufacture and sale of blood glucose measuring system and cirrhosis testing system. Its products include Test sheet and Glucose machine. Geographically it operates in Germany, Iran, Kingdom of Saudi Arabia, Switzerland, Las Vegas, and Others with majority of the revenue deriving from Germany.
63GF Score
Get the complete analysis for ROCO:4183
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4183 has been successfully added to your 
